Conferences like @ASAMorg’s annual meeting remind us how quickly the science of #AddictionMedicine is advancing. Together, we can continue to translate science into solutions that support recovery. #ASAM2026 #OpioidUseDisorder #PoweringRecovery #RoadToRecovery

Indivior’s CEO and CFO will be at Jefferies' Healthcare Conference, participating in a Fireside chat and hosting meetings for #investors. Please contact your Jefferies rep to schedule a meeting, and listen to the publicly available Fireside chat: social.indivior.com/m/0SKaIx…

New research shows that adherence to long-acting injectables for #OpioidUseDisorder is associated with lower relapse risk and reduced all-cause healthcare utilization, including fewer acute care visits. Read more: social.indivior.com/m/njqZgI… #OUD #PoweringRecovery

We are at @ASAMorg's conference this week presenting two posters about our commitment to advancing evidence-based treatment for #OUD as a chronic but treatable brain disease. Visit Indivior at booth #301 to learn more. Explore the full poster schedule: social.indivior.com/m/g5bBxW…

New key insights highlight the role of long-acting injectable buprenorphine in addressing staffing gaps and diversion risk of medications for opioid use disorder (#MOUD) in correctional settings. Explore the data: social.indivior.com/m/Mkv0yW… #OpioidUseDisorder #PoweringRecovery

News for #investors and #media: Indivior announces Q3 2024 financial results. Please read the press release here: indivior.com/en/media

According to a research report by the National Institutes on Drug Abuse, “multiple national population surveys have found that about half of those who experience a mental illness during their lives will also experience a substance use disorder (SUD) and vice versa*.” These comorbidities play a role in making every patient’s recovery journey unique. Our Guiding Principle to “focus on patient needs to drive decisions,” means we support the patient's journey from treatment and recovery by providing education, new scientific understanding, and knowledge to the treatment community. *ncbi.nlm.nih.gov/books/NBK57…

During Substance Use Prevention Month we recognize that substance use disorder (SUD) can affect any of us. Your sibling, child, parent, friend, coworker or others could be struggling with SUD and searching for help. At Indivior we want to thank the people and community leaders working every day to promote prevention and early intervention strategies so that more people suffering from SUD have access to care. Together, we can create a brighter future for people experiencing SUD. To learn more about prevention resources and events, visit SAMHSA’s website: samhsa.gov/find-help/atod/re…

We have released our 2023 Sustainability Report. This report summarizes Indivior’s global environmental, social, and governance approach, and related activities and performance. To read the full report visit indivior.com/en/responsibili… social.indivior.com/u/TVOelh

At Indivior we acknowledge and celebrate the power of recovery. Navigating the complexities of substance use disorder (SUD) can be overwhelming but we believe that anyone suffering with SUD should have access to evidence-based treatments to help achieve recovery. Together, we work to understand recovery in its full continuum so we can help create a brighter future of hope and recovery for more people. To find support resources please visit SAMHSA’s website: samhsa.gov/find-support/help… #Recovery #EndtheStigma

On International Overdose Awareness Day, we want to raise awareness about the significant role we all play in preventing overdose deaths. Together, we can help raise awareness about overdose, reduce the stigma, and help improve access to rescue treatments that can save lives. So, today let’s remember the lives of those impacted by overdose and come together to help create a world free of overdose deaths. To learn more about evidence-based resources for opioid overdose visit: hhs.gov/overdose-prevention/ #TogetherWeCan #EndOverdose #IOAD2024

For #media: Today Indivior announced a milestone in our contract with Biomedical Advanced Research and Development Authority (BARDA) so that communities will be better equipped to respond to emergencies and address biosecurity threats involving synthetic opioids. To read the press release, please visit: indivior.com/media

During Overdose Awareness Week we join with the individuals, families and communities who have been impacted by overdose. According to the Center for Disease Control (CDC), 70,972 people have lost their lives to synthetic opioid overdose in the 12-months ending in March 2024*. To learn more about overdose prevention strategies visit the U.S. Health and Human Services Department’s website: hhs.gov/overdose-prevention/ *CDC: cdc.gov/nchs/nvss/vsrr/drug-…

News for #investors and #media: Indivior announces Q2 and H1 2024 financial results. Please read the press release here: indivior.com/en/media

Today marks International Day Against Drug Abuse and Illicit Trafficking, or World Drug Day. According to the United Nations Office on Drugs and Crime (UNODC), the number of people with drug use disorder has increased 45% in the past ten years*. At Indivior, it is our vision that the people across the globe battling substance use disorders have access to the evidence-based treatments they need to transform their lives. To learn more visit: un.org/en/observances/end-dr… *Reference: unodc.org/res/WDR-2023/Speci…

Today we recognize Juneteenth which commemorates the effective emancipation of enslaved African Americans, when on June 19th of 1865 Union soldiers arrived in Galveston, Texas to enforce the Emancipation Proclamation. During this important observance, we encourage everyone to reflect on Black history and honor the resilience of those who had to fight for freedom.

In celebration of Pride Month, Indivior is pleased to take this opportunity to recognize the contributions the LGBTQI+ community has made to our company culture and our communities. We are inspired by our people and culture each day. Through their expertise, insights and innovations we aim to address patients’ unmet needs around the world.

Indivior was proud to attend the Opioid Overdose Reversal Medication (OORM) Manufacturers Meeting and reaffirm our commitment to expanding national access to all lifesaving, FDA-approved reversal medications. Ending the opioid crisis requires a collective effort from all stakeholders and we commend the Office of National Drug Control Policy’s (ONDCP) leadership and collaboration in convening the meeting. Learn more: indivior.com/en/media/compan…

On World Schizophrenia Day, we advocate to improve mental health services and policies that prioritize the needs of individuals with schizophrenia. Together, we can promote acceptance, raise awareness, and drive positive change. To learn more about schizophrenia, visit the World Health Organization’s website: who.int/news-room/fact-sheet…